Covidh Technologies Limited Stock Price Today (NSE: COVIDH)
Covidh Technologies Limited
Fundamental Score
Covidh Technologies Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Covidh Technologies Limited share price today is ₹143.90, up +0.00% on NSE/BSE as of 1 August 2026. Covidh Technologies Limited (COVIDH) is a Small-cap company in the Computers - Software & Consulting sector with a market capitalisation of ₹121.01 (Cr). The 52-week high for COVIDH share price is ₹143.90 and the 52-week low is ₹3.07. At a P/E ratio of 465.42x, COVIDH is currently trading above its industry average P/E of 22.33x. The company has a Return on Equity (ROE) of 6.38% and a debt-to-equity ratio of 0.20.
Covidh Technologies Limited Share Price Chart — NSE/BSE Historical Performance
Covidh Technologies Limited share price chart: 11.39% return over the past month. 52-week high ₹143.90, 52-week low ₹3.07.
Covidh Technologies Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 1.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 941.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 0.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 30.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 968.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 129.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 119.00 (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 1.05K (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 1.20K (Cr) | |
| ₹143.90 | ₹143.90 | ₹143.90 | ₹143.90 | 9.90K (Cr) |
Covidh Technologies Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹131.75 | ₹143.90 | ₹131.75 | ₹143.90 | +9.22% | |
| ₹77.49 | ₹129.18 | ₹77.49 | ₹129.18 | +66.71% | |
| ₹77.49 | ₹77.49 | ₹77.49 | ₹77.49 | +0.00% | |
| ₹56.26 | ₹77.49 | ₹56.26 | ₹77.49 | +37.74% | |
| ₹38.69 | ₹55.16 | ₹38.69 | ₹55.16 | +42.57% | |
| ₹26.12 | ₹37.94 | ₹26.12 | ₹37.94 | +45.25% | |
| ₹17.31 | ₹25.11 | ₹17.31 | ₹25.11 | +45.06% | |
| ₹11.29 | ₹16.98 | ₹11.29 | ₹16.98 | +50.40% | |
| ₹8.14 | ₹11.07 | ₹8.14 | ₹11.07 | +36.00% | |
| ₹6.60 | ₹7.99 | ₹6.60 | ₹7.99 | +21.06% | |
| ₹4.44 | ₹6.48 | ₹4.44 | ₹6.48 | +45.95% | |
| ₹3.13 | ₹4.36 | ₹3.13 | ₹4.36 | +39.30% |
AI Research Briefing
Powered by Gemini · 2026-08-01
A shell-company reverse merger pump disguised as a tech stock, where 465x P/E leaves zero margin for execution error.
WHAT'S HAPPENING NOW (last 2-4 weeks)
The corporate restructurings follow an April 2026 postal ballot and June 26, 2026 corrigendum for a preferential share swap to acquire 100% of iSERA Biological Limited, alongside changing the company name to iSERA Lifesciences Limited. Standalone Q4 FY26 net profit surged 139.13% YoY to ₹0.55 Cr against ₹0.23 Cr in the prior period.
CORE STORY (THE REAL GAME)
This is not a software consulting play; it is a backdoor reverse merger asset injection trade. Legacy IT operations (5Y sales CAGR down 8.58%) are being shell-swapped for a biological science business, backed by a massive promoter stake increase of 55.06% to 58.63%.
- Preferential share swap announced to acquire 100% stake in iSERA Biological Limited.
- Name change to iSERA Lifesciences Limited driving speculative pivot narrative.
- Promoter stake surged 55.06% to 58.63% alongside Q4 FY26 net profit of ₹0.55 Cr.
- Definitive regulatory and shareholder approval for iSERA Biological share swap.
- First combined earnings readout post-merger integration.
- Severe profit-booking due to extreme 465x P/E valuation.
- Severe micro-cap illiquidity risk with zero FII/DII participation.
- 5-year cumulative Free Cash Flow sits deep in the red at ₹-7.23 Cr.
- Massive valuation stretch at 465.42x P/E vs industry average 22.33x.
Promoter increased stake by 55.06% to 58.63%; FII and DII holdings remain at 0.0%.
Indian IT consulting growth (+24% cloud expansion) is irrelevant here as the company pivots completely into biotech.
Executing 100% equity acquisition of iSERA Biological Limited via share swap.
No, 5-year Free Cash Flow stands negative at ₹-7.23 Cr.
Subsequent 3-6 month performance hinges entirely on post-merger integration of iSERA Biological. Extreme downside risk exists if execution fails to justify the inflated valuation.
Primary Thesis Risk
Execution failure or regulatory rejection of the iSERA Biological share swap.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Covidh Technologies Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Covidh Technologies Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of COVIDH across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Robust Profit Growth (139.13%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (36.78% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Conservative Debt Levels (D/E: 0.20)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (58.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (6.38%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (5.95%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 465.42x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Limited Growth History (-8.58% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Stagnant Profit Growth (-31.94% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-7.23 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Covidh Technologies Limited vs Computers - Software & Consulting Peers
Peer Comparison - Computers - Software & Consulting
Compare Covidh Technologies Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Covidh Technologies LimitedCovidh Technolo...Selected✓ COVIDH • 534920 | 26.8/100 | ₹143.90₹144 | ₹121.01₹121.01 | 465.42Average 465.4 Average | 6.38%Poor 6.38% Poor | 5.95%Poor 5.95% Poor | 0.20Excellent 0.2 Excellent | -31.94%Poor -31.94% Poor | -8.58%Poor -8.58% Poor | 0.00% |
Tata Consultancy Services LtdTata Consultanc... TCS • 532540 | 65.4/100 | ₹2365.60₹2366 | ₹791945.76₹791945.76 | 14.75Average 14.8 Average | 51.81%Excellent 51.81% Excellent | 63.03%Excellent 63.03% Excellent | 0.11Excellent 0.1 Excellent | 9.45%Good 9.45% Good | 10.22%Good 10.22% Good | 2.92% |
Infosys LtdInfosys Ltd... INFY • 500209 | 60.4/100 | ₹1130.10₹1130 | ₹437177.23₹437177.23 | 14.53Average 14.5 Average | 31.89%Excellent 31.89% Excellent | 39.95%Excellent 39.95% Excellent | 0.10Excellent 0.1 Excellent | 9.29%Good 9.29% Good | 12.20%Good 12.20% Good | 4.46% |
HCL Technologies LimitedHCL Technologie... HCLTECH • 532281 | 65.8/100 | ₹1346.90₹1347 | ₹316874.61₹316874.61 | 17.48Average 17.5 Average | 23.98%Excellent 23.98% Excellent | 30.60%Excellent 30.60% Excellent | 0.07Excellent 0.1 Excellent | 9.57%Good 9.57% Good | 11.54%Good 11.54% Good | 4.62% |
Wipro LtdWipro Ltd... WIPRO • 507685 | 49.2/100 | ₹176.08₹176 | ₹173010.39₹173010.39 | 13.14Average 13.1 Average | 15.46%Good 15.46% Good | 17.84%Good 17.84% Good | 0.23Excellent 0.2 Excellent | 4.05%Average 4.05% Average | 8.38%Good 8.38% Good | 6.30% |
Tech Mahindra LtdTech Mahindra L... TECHM • 532755 | 41.9/100 | ₹1651.30₹1651 | ₹146940.68₹146940.68 | 29.42Average 29.4 Average | 17.53%Good 17.53% Good | 23.12%Excellent 23.12% Excellent | 0.07Excellent 0.1 Excellent | 2.44%Average 2.44% Average | 8.46%Good 8.46% Good | 3.40% |
LTIMindtree LimitedLTIMindtree Lim... LTIM • 540005 | 74.7/100 | ₹4380.60₹4381 | ₹120235.26₹120235.26 | 21.43Average 21.4 Average | 23.13%Excellent 23.13% Excellent | 29.60%Excellent 29.60% Excellent | 0.10Excellent 0.1 Excellent | 22.79%Excellent 22.79% Excellent | 27.88%Excellent 27.88% Excellent | 1.85% |
Persistent Systems LtdPersistent Syst... PERSISTENT • 533179 | 63.8/100 | ₹5549.00₹5549 | ₹80072.30₹80072.30 | 41.53Average 41.5 Average | 27.24%Excellent 27.24% Excellent | 34.36%Excellent 34.36% Excellent | 0.06Excellent 0.1 Excellent | 35.85%Excellent 35.85% Excellent | 28.63%Excellent 28.63% Excellent | 0.69% |
Coforge LimitedCoforge Limited... COFORGE • 532541 | 69.2/100 | ₹1721.00₹1721 | ₹67910.23₹67910.23 | 41.35Average 41.4 Average | 20.64%Excellent 20.64% Excellent | 23.50%Excellent 23.50% Excellent | 0.08Excellent 0.1 Excellent | 28.45%Excellent 28.45% Excellent | 28.60%Excellent 28.60% Excellent | 0.99% |
Mphasis LtdMphasis Ltd... MPHASIS • 526299 | 46/100 | ₹2342.30₹2342 | ₹44659.24₹44659.24 | 23.65Average 23.6 Average | 18.53%Good 18.53% Good | 22.09%Excellent 22.09% Excellent | 0.24Excellent 0.2 Excellent | 9.19%Good 9.19% Good | 10.31%Good 10.31% Good | 2.65% |
Hexaware Technologies LtdHexaware Techno... HEXT • 544362 | 58.6/100 | ₹561.65₹562 | ₹34454.91₹34454.91 | 23.50Average 23.5 Average | 24.86%Excellent 24.86% Excellent | 30.07%Excellent 30.07% Excellent | 0.11Excellent 0.1 Excellent | 18.49%Excellent 18.49% Excellent | 16.49%Excellent 16.49% Excellent | 2.04% |
Top Computers - Software & Consulting Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Tata Consultancy Services Ltd share price791945.76 Cr
- Infosys Ltd share price437177.23 Cr
- HCL Technologies Limited share price316874.61 Cr
- Wipro Ltd share price173010.39 Cr
- Tech Mahindra Ltd share price146940.68 Cr
Covidh Technologies Limited Quarterly Performance
Latest quarterly metrics for COVIDH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
139.13%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-8.58%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-31.94%
Compounded annual net profit growth over 5 years
Covidh Technologies Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for COVIDH — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Covidh Technologies Limited Financial Statements
Annual income statement, balance sheet and cash flow for Covidh Technologies Limited (COVIDH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Covidh Technologies Limited
About COVIDH (Covidh Technologies Limited)
Covidh Technologies Limited is a cutting-edge solutions provider specializing in comprehensive software development and IT consulting services. Born from a vision to empower busine...sses in the digital age, COVIDH crafts bespoke software applications, implements robust cloud infrastructures, and offers strategic IT guidance to companies across diverse industries. We prioritize innovation and scalability, ensuring our clients are equipped to thrive in a rapidly evolving technological landscape. From initial concept design to seamless deployment and ongoing support, COVIDH acts as a dedicated partner, helping businesses unlock their full potential through tailored technology solutions. We are committed to leveraging the latest advancements in AI, machine learning, and data analytics to deliver exceptional results and drive significant business impact. COVIDH distinguishes itself through its unwavering focus on client-centricity and a commitment to building long-term partnerships. Our team of experienced software engineers, IT consultants, and project managers work collaboratively with clients to understand their unique challenges and objectives. This collaborative approach allows us to develop customized solutions that address specific needs and drive measurable results. We excel in providing end-to-end services, covering everything from initial business analysis and requirements gathering to software design, development, testing, and deployment. Furthermore, COVIDH offers ongoing maintenance and support to ensure our solutions remain optimized and aligned with evolving business demands. Our goal is to be a trusted technology advisor, enabling our clients to achieve their strategic goals and maintain a competitive edge. Headquartered in Hyderabad, India, COVIDH fosters a dynamic and collaborative work environment that attracts top talent in the IT industry. We are dedicated to fostering a culture of continuous learning and innovation, empowering our employees to stay ahead of the curve and deliver exceptional service. Our commitment to ethical business practices and social responsibility underpins everything we do. COVIDH strives to create a positive impact on the communities we serve and build a sustainable future. By focusing on innovation, client satisfaction, and employee growth, we are positioned to be a leader in the software development and IT consulting space, driving value for our clients and stakeholders alike.
Company Details
Key Leadership
Corporate Events
Latest News
COVIDH Share Price: Frequently Asked Questions
What is the current share price of Covidh Technologies Limited?
Covidh Technologies Limited (COVIDH) trades at ₹143.90 on NSE and BSE. Market cap ₹121.01 (Cr). Educational data only.
What is the P/E ratio of Covidh Technologies Limited?
Covidh Technologies Limited has a P/E of 465.42x vs industry average 22.33x.
What is the Bull Run score for Covidh Technologies Limited?
Covidh Technologies Limited has a Bull Run score of 26.8/100 based on 25+ financial parameters.
Does Covidh Technologies Limited pay dividends?
Covidh Technologies Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Covidh Technologies Limited?
Covidh Technologies Limited has ROE of 6.38%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Covidh Technologies Limited?
Covidh Technologies Limited has debt-to-equity of 0.20.
Is Covidh Technologies Limited a good investment?
Bull Run gives Covidh Technologies Limited a score of 26.8/100. This is not investment advice — consult a SEBI-registered advisor.